We are live on ! Find out more
PJP icon

Invesco Pharmaceuticals ETF
PJP

82 hedge funds and large institutions have $64.8M invested in Invesco Pharmaceuticals ETF in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.09% less ownership

Funds ownership: 16.87% → 14.78% (-2.1%)

12% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 26

13% less funds holding

Funds holding: 94 → 82 (-12)

13% less capital invested

Capital invested by funds: $74.5M → $64.8M (-$9.65M)

71% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 17

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
82
Holders Change
-12
Holders Change %
-12.77%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
23
Reduced
26
Closed
17
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$2.04M
2
Citigroup
Citigroup
New York
+$464K
3
Chevy Chase Trust
Chevy Chase Trust
Maryland
+$204K
4
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$187K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
+$187K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.41M
2
UBS Group
UBS Group
Switzerland
-$2.09M
3
CS
Credit Suisse
Switzerland
-$1.37M
4
Citadel Advisors
Citadel Advisors
Florida
-$950K
5
TRCT
Tower Research Capital (TRC)
New York
-$637K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
51
CAPTRUST Financial Advisors
North Carolina
$143K – – –
SPIA
52
Steward Partners Investment Advisory
New York
$122K +$23.7K +300 +25%
JP Morgan Chase
53
JP Morgan Chase
New York
$98K +$10.8K +137 +13%
HI
54
Harbour Investments
Wisconsin
$91K -$13.8K -175 -14%
Marshall Wace
55
Marshall Wace
United Kingdom
$75K +$72.9K +922 New
SSB
56
Sandy Spring Bank
Maryland
$69K – – –
HCM
57
Highlander Capital Management
New Jersey
$65K – – –
NSIM
58
North Star Investment Management
Illinois
$49K – – –
AWMS
59
Advocacy Wealth Management Services
Georgia
$44K -$14.6K -185 -26%
PNC Financial Services Group
60
PNC Financial Services Group
Pennsylvania
$41K – – –
CIAS
61
Capital Investment Advisory Services
North Carolina
$39K +$79 +1 +0.2%
AFS
62
Annapolis Financial Services
Maryland
$28K – – –
IA
63
IFP Advisors
Florida
$27K -$3.16K -40 -11%
POIA
64
Pin Oak Investment Advisors
Texas
$22K – – –
GWM
65
Geneos Wealth Management
Colorado
$16K – – –
Fidelity Investments
66
Fidelity Investments
Massachusetts
$13K +$3.79K +48 +43%
Koshinski Asset Management
67
Koshinski Asset Management
Illinois
$12.2K – – –
HIA
68
Harbor Investment Advisory
Maryland
$12K – – –
CSWM
69
Cassady Schiller Wealth Management
Ohio
$12K +$11.9K +150 New
PSB
70
Piscataqua Savings Bank
New Hampshire
$9K – – –
RDFA
71
Ritter Daniher Financial Advisory
Ohio
$9K – – –
TCM
72
Tradewinds Capital Management
Washington
$9K – – –
SWM
73
Selective Wealth Management
Virginia
$8K – – –
DAM
74
Delta Asset Management
Tennessee
$2K -$7.9K -100 -80%
WT
75
Whittier Trust
California
$2K – – –
1 2
3
4

PJP Hedge Fund Activity: Q4 2021 in Review

82 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2021, worth a combined $64.8M — down 13% from $74.5M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of PJP and 5 opened new positions — a net loss of 12 holders — while 26 trimmed existing stakes and 23 added.

The largest buyer was Wells Fargo, adding an estimated $2.04M. The largest seller was Wellington Management Group, exiting entirely with an estimated $7.41M sold.

  • 82 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2021, down from 94 in Q3 2021.
  • Funds reported $64.8M of Invesco Pharmaceuticals ETF stock for Q4 2021, down 13% quarter-over-quarter.
  • 5 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2021 and 17 closed out, a net change of -12 holders.
  • The largest Invesco Pharmaceuticals ETF buyer in Q4 2021 was Wells Fargo, an estimated $2.04M added.
  • The largest Invesco Pharmaceuticals ETF seller in Q4 2021 was Wellington Management Group, an estimated $7.41M sold.

Based on aggregated 13F filings for Q4 2021.